LDR SPINE ROI-C IMPLANT

K083857 · Ldr Spine USA · MQP · Feb 12, 2009 · Orthopedic

Device Facts

Record IDK083857
Device NameLDR SPINE ROI-C IMPLANT
ApplicantLdr Spine USA
Product CodeMQP · Orthopedic
Decision DateFeb 12, 2009
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3060
Device ClassClass 2
AttributesTherapeutic

Intended Use

The ROI-C is indicated for use to replace a vertebral body that has been resected or excised due to tumor or trauma/fracture. The device is intended for use as a partial vertebral body replacement in the thoracolumbar spine (from T1 to L5) and is intended for use with supplemental internal fixation. The ROI-C is intended to be implanted in pairs. Supplemental internal fixation is required to properly utilize this system.

Device Story

ROI-C implants are D-shaped blocks of varying heights and dimensions; designed for partial vertebral body replacement in thoracolumbar spine (T1-L5). Implants feature closed graft space and teeth on superior/inferior surfaces for stability. Manufactured from radiolucent PEEK; compatible with titanium anchor plates. Implanted in pairs by surgeons; requires supplemental internal fixation. Provides structural support to replace resected/excised vertebral bodies.

Clinical Evidence

Bench testing only.

Technological Characteristics

D-shaped blocks; material: radiolucent PEEK; surface features: teeth for stability; compatible with titanium anchor plates; intended for thoracolumbar implantation.

Indications for Use

Indicated for patients requiring partial vertebral body replacement in the thoracolumbar spine (T1-L5) following resection or excision due to tumor or trauma/fracture. Must be used in pairs with supplemental internal fixation.

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K083857 Page 1 of 2 FEB 1 2 2009 Image /page/0/Picture/2 description: The image shows the logo for LDR, which includes a stylized eye graphic to the left of the letters "LDR". Below the letters, the text "a passion for innovation" is written in a smaller font. The logo appears to be for a company or organization that values innovation. #### 510(k) Summary #### LDR Spine USA ROI-C Partial Vertebral Body Replacement System #### 1. Owner's Name & Address LDR Spine USA 4030 West Braker Lane, Suite 360 Austin, TX 78759 (512) 344-3333 Phone: Fax: (512) 344-3350 ## 2. Contact Person Noah Bartsch MS, RAC, Manager, Clinical, Regulatory & Quality Affairs LDR Spine USA 4030 West Braker Lane, Suite 360 ·Austin, TX 78759 (512) 344-3319 Phone: Fax: (512) 344-3350 noahbartsch@ldrspine.com Email: ## 3. Date 510(k) Summary Prepared December 23, 2008 LDR Spine ROI-C System 4. Trade Name Spinal Partial Vertebral Body Replacement Device Common Name Classification MQP Spinal Intervertebral Body Fixation Orthosis - Class II per 888.3060 ## 5. Legally Marketed Equivalent Predicate Device LDR Spine ROI-C Partial Vertebral Body Replacement System (K080728) LDR Spine MC+ Partial Vertebral Body Replacement System (K043479) {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows a logo with an abstract graphic on the left and the letters "LDR" on the right. The graphic on the left appears to be a stylized eye or a circular shape with an opening. The letters "LDR" are in a bold, sans-serif font and are connected to the graphic on the left. The logo has a textured appearance, possibly due to the image being a scan or a low-resolution file. a passion for innovation ## 6. Device Description The ROI-C Implants are D-shaped blocks in a variety of heights and length x width combinations. The ROI-C implants feature a closed graft space and the inferior and superior surface of the devices have a patter n of teeth to provide increased stability. The devices are manufactured from radiolucent PEEK, and are compatible with titanium anchor plates available for use with the ROI-C system. The purpose of this submission is to obtain clearance for a modified design of the ROI-C implants. #### 7. Intended Use of the device The ROI-C is indicated for use to replace a vertebral body that has been resected or excised due to tumor or trauma/fracture. The device is intended for use as a partial vertebral body replacement in the thoracolumbar spine (from T1 to L5) and is intended for use with supplemental internal fixation. The ROI-C is intended to be implanted in pairs. Supplemental internal fixation is required to properly utilize this system. #### 8. Non-Clinical Performance Data Results of the non-clinical analysis and verification activities indicate that the proposed ROI-C system is substantially equivalent to the predicate device system. {2}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, clutching a caduceus, a symbol of medicine, in its talons. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" are arranged in a circular pattern around the eagle. #### Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Public Health Service LDR Spine USA % Mr. Noah Bartsch, MS. RAC Manager, Clinical, Regulatory & Quality Affairs 4030 West Braker Lane, Suite 360 Austin, Texas 78759 FEB 1 2 2009 Re: K083857 Trade/Device Name: LDR Spine ROI-C Implant Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: II Product Code: MQP Dated: January 23, 2009 Received: January 26, 2009 Dear Mr. Bartsch: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device cans be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ # Page 2 - Mr. Noah Bartsch This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Mark A. Melkerson Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K083857 Page 1 of 1 g # Indications for Use Statement Page 1 of 1 510(k) Number (if known): Device Name: LDR Spine ROI-C Implant Indications for Use: The ROI-C is indicated for use to replace a vertebral body that has been resected or excised due to tumor or traumalfracture. The device is intended for use as a partial vertebral body replacement in the thoracolumbar spine (from T1-to L5) and is intended for use with supplemental internal fixation. The ROI-C is intended to be implanted in pairs. Supplemental internal fixation is required to properly utilize this system. Prescription Use AND/OR × (Part 21 CFR 801 Subpart D) OR O Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Mark A. Milliken (Division Sign-Off) Division of General, Restorative, and Neurological Devices 1 510(k) Number
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%